person · Reporting owner
Douglas Robert Andrew
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 15,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 15,000 · Balance 15,000 F1: These options were granted on January 21, 2026, and will vest on January 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and will vest on January 1, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date January 02, 2024 · Filed January 03, 2024
Section 16 reporting ended · disclosed 2024-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 11,080 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,080 F1: Mr. Douglas is no longer subject to reporting under his new role. |
| ResMed Common StockSEC Table I · non-derivative | IndirectDouglas Family Trust | 253,295 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 253,295 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Douglas is no longer subject to reporting under his new role.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 18, 2022 Filed Jan 20, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $247.80 | $1,982,400.00 |
DisclosureSEC source: 0001127602-22-001741 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,175 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-22-001741 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:24 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-031222 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:24 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $256.52 | $2,052,160.00 |
DisclosureSEC source: 0001127602-21-031222 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,175 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:24 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-031222 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 23, 2021 Filed Nov 30, 2021 02:56 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-029820 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 234,995 F1 · kind: Represents a gift of shares to Fidelity Charitable, a donor advised fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares. F2 · balance_after: Includes a transfer of shares between direct and indirect holdings on 11/23/2021. Read SEC document |
| November 18, 2021 Filed Nov 18, 2021 22:01 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 2,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-029557 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,554 F3 · kind: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| November 18, 2021 Filed Nov 23, 2021 00:53 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 15,252 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0000943819-21-000038 · primary_doc.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,252 Underlying: ResMed Common Stock · 15,252 shares Expires 2028-11-18 F1 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2022, 2023 and 2024. Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 22:01 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 27,135 | $254.81 | $6,914,269.35 |
DisclosureSEC source: 0001127602-21-029557 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,942 F2 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 22:01 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 45,811 | $254.81 | $11,673,100.91 |
DisclosureSEC source: 0001127602-21-029557 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,077 F1 · kind: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 01:44 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-029234 · form4.xml · derivative · entry 5 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transaction was conducted under a Rule 10b5-1 plan. F4 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 01:44 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $271.75 | $2,174,000.00 |
DisclosureSEC source: 0001127602-21-029234 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,266 F3 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 01:44 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-029234 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 01:44 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 945 | $259.47 | $245,199.15 |
DisclosureSEC source: 0001127602-21-029234 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,266 F1 · kind: Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/19/2020. F2 · balance_after: Includes 62.8289 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:28 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-027245 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:28 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $255.77 | $2,046,160.00 |
DisclosureSEC source: 0001127602-21-027245 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:28 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-027245 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 19:08 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-025396 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 19:08 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $291.83 | $2,334,640.00 |
DisclosureSEC source: 0001127602-21-025396 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 19:08 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-025396 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 15:56 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 5,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024087 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149 F1 · kind: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 18:06 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-023841 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 18:06 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $275.57 | $2,204,560.00 |
DisclosureSEC source: 0001127602-21-023841 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,767 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 18:06 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-023841 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:36 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-022126 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:36 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $248.00 | $1,984,000.00 |
DisclosureSEC source: 0001127602-21-022126 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,767 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:36 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-022126 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:04 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-020062 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:04 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $232.10 | $1,856,800.00 |
DisclosureSEC source: 0001127602-21-020062 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,767 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 21:04 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-020062 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:49 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-21-017340 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:49 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-21-017340 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 65.09 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:49 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $195.00 | $1,560,000.00 |
DisclosureSEC source: 0001127602-21-017340 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,766 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 19:12 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 964 | $207.45 | $199,981.80 |
DisclosureSEC source: 0001127602-21-013832 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 210,407 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 22:31 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,081 | $185.48 | $200,503.88 |
DisclosureSEC source: 0001127602-21-010864 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 211,371 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:47 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 998 | $200.46 | $200,059.08 |
DisclosureSEC source: 0001127602-21-006245 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 212,452 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 18, 2021 Filed Jan 20, 2021 00:55 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 4,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002063 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,701 F1 · shares: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on January 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 22:24 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 938 | $212.86 | $199,662.68 |
DisclosureSEC source: 0001127602-21-002006 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 213,450 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004038 · doc4.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 19:58 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 970 | $207.80 | $201,566.00 |
DisclosureSEC source: 0001127602-20-031504 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 214,388 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 16:50 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 478 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-029982 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 215,358 F2 · kind: Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 16:50 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 955 | $211.00 | $201,505.00 |
DisclosureSEC source: 0001127602-20-029982 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 215,836 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 19, 2020 Filed Nov 21, 2020 01:12 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 20,388 | $0.00 Strike: $211.76 | $0.00 |
DisclosureSEC source: 0001127602-20-029772 · form4.xml · derivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,388 Underlying: ResMed Common Stock · 20,388 shares Expires 2027-11-19 F1 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2021, 2022 and 2023. Read SEC document |
| November 19, 2020 Filed Dec 1, 2020 23:11 UTC Amendment | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 20,776 | $0.00 Strike: $211.76 | $0.00 |
DisclosureSEC source: 0001127602-20-030246 · form4a.xml · derivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,776 Underlying: ResMed Common Stock · 20,776 shares Expires 2027-11-19 F1 · shares: Corrects original reported option grant for updated Black-Scholes valuation. F1 · derivative.underlying_shares: Corrects original reported option grant for updated Black-Scholes valuation. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 18:52 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 34,958 | $214.74 | $7,506,880.92 |
DisclosureSEC source: 0001127602-20-029546 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,080 F2 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 18:52 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 59,057 | $214.74 | $12,681,900.18 |
DisclosureSEC source: 0001127602-20-029546 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,038 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on November 17, 2020, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 22:43 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,717 | $212.11 | $364,192.87 |
DisclosureSEC source: 0001127602-20-029014 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,981 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 76.92 shares of ResMed stock purchased on October 31, 2020, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:04 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,125 | $176.72 | $198,810.00 |
DisclosureSEC source: 0001127602-20-027196 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 182,313 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 21:01 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,147 | $175.49 | $201,287.03 |
DisclosureSEC source: 0001127602-20-025213 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 183,438 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 20:36 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | PurchaseClass A Common Stock | 615 | $53.88 | $33,136.20 |
DisclosureSEC source: 0001209191-20-048231 · doc4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,005 F1 · kind: This purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.